Balyasny Asset Management »

First Tracks Biotherapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $14M 715k 20.12

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Select Sector Spdr Tr St Str Finl Etf Call Option (XLF)
Meta Platforms Cl A Call Option (META)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Microsoft Corporation Call Option (MSFT)
Tesla Motors Call Option (TSLA)

View all positions for Balyasny Asset Management

Top funds holding First Tracks Biotherapeutics

FMR
Affinity Asset Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Sanofi
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management
Vanguard Portfolio Management
Goldman Sachs Group
Point72 Asset Management
Arrowstreet Capital, Limited Partnership
Federated Investors
Ally Bridge Group

View all funds holding First Tracks Biotherapeutics